PHAXIAM Therapeutics S.A. (LON: 0QSS)
London
· Delayed Price · Currency is GBP · Price in EUR 1.820
+0.070 (4.00%)
Jan 21, 2025, 8:50 AM BST
PHAXIAM Therapeutics Market Cap
PHAXIAM Therapeutics has a market cap or net worth of 15.14 million as of January 23, 2025. Its market cap has decreased by -30.47% in one year.
Market Cap
15.14M
Enterprise Value
17.50M
Revenue
1.82M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.82
Market Cap Chart
Since May 7, 2013, PHAXIAM Therapeutics's market cap has decreased from 44.22M to 15.14M, a decrease of -65.76%. That is a compound annual growth rate of -8.74%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 171.37B |
| GSK plc | 55.43B |
| Haleon | 33.25B |
| Smith & Nephew | 9.04B |
| ConvaTec Group | 4.92B |
| Hikma Pharmaceuticals | 4.68B |
| HUTCHMED (China) | 1.94B |
| Oxford Nanopore Technologies | 1.48B |